---
figid: PMC6722273__in-19-e23-g002
figlink: /pmc/articles/PMC6722273/figure/F2/
number: F2
caption: . Inhibition of anti-tumor immune response. The purinergic pathway through
  adenosine molecules creates an immunosuppressive and tolerogenic condition in the
  tumor medium. The biologic function of different immune cells such as T cells, DCs,
  MDSCs, NK cells, macrophages, and neutrophils are influenced by adenosine, and aid
  in tumor progression.
pmcid: PMC6722273
papertitle: Adenosine Blockage in Tumor Microenvironment and Improvement of Cancer
  Immunotherapy.
reftext: Samaneh Arab, et al. Immune Netw. 2019 Aug;19(4):e23.
pmc_ranked_result_index: '27049'
pathway_score: 0.7111855
filename: in-19-e23-g002.jpg
figtitle: Adenosine Blockage in Tumor Microenvironment and Improvement of Cancer Immunotherapy
year: '2019'
organisms: Homo sapiens
ndex: 74f27d8f-de9a-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6722273__in-19-e23-g002.html
  '@type': Dataset
  description: . Inhibition of anti-tumor immune response. The purinergic pathway
    through adenosine molecules creates an immunosuppressive and tolerogenic condition
    in the tumor medium. The biologic function of different immune cells such as T
    cells, DCs, MDSCs, NK cells, macrophages, and neutrophils are influenced by adenosine,
    and aid in tumor progression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PGF
  - VEGFB
  - VEGFC
  - CD4
  - MFAP1
  - ENTPD1
  - CD8B
  - VEGFD
  - NT5E
  - CD8A
  - VEGFA
  - Adenosine
  - AMP
  - ATP
  - Cytotoxic
  - Cytotoxicity
  - tumor
genes:
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: CD4+
  symbol: CD4
  source: hgnc_symbol
  hgnc_symbol: CD4
  entrez: '920'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: CD39
  symbol: CD39
  source: hgnc_prev_symbol
  hgnc_symbol: ENTPD1
  entrez: '953'
- word: CD8+
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: CD73
  symbol: CD73
  source: hgnc_alias_symbol
  hgnc_symbol: NT5E
  entrez: '4907'
- word: CD8+
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
chemicals:
- word: Adenosine
  source: MESH
  identifier: D000241
- word: AMP
  source: MESH
  identifier: D000249
- word: ATP
  source: MESH
  identifier: D000255
diseases:
- word: Cytotoxic
  source: MESH
  identifier: D064420
- word: Cytotoxicity
  source: MESH
  identifier: D064420
- word: tumor
  source: MESH
  identifier: D009369
figid_alias: PMC6722273__F2
redirect_from: /figures/PMC6722273__F2
figtype: Figure
---
